Barclays Maintains Rivian’s $14 Price Target

Barclays analyst Dan Levy reiterated on February 10, 2026, an ‘Equalweight’ rating and $14 price target on Rivian.

“Key takes

1. Sentiment leaning negative into 4Q EPS, following period of excitement late-’25, negative fundamentals now more in focus;
2. We expect EBITDA guide of ~-$2bn and deliveries of 48k, both below cons on lower R2 volume;
3. Tech licensing deal not expected at 4Q, but likely in the future.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.